Pelthos Therapeutics Inc. (PTHS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Pelthos Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Pelthos Therapeutics Inc. (PTHS) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $56M. It trades at $15.74, up 8.55% today. 5 analysts' average target of $48.40 implies +207.5% from today's price. Kronos AI's 30-day forecast is +79.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $48.40 |
| Low – high | $30.00 – $64.00 |
| Analysts | 5 |
| Upside to average | +207.5% |
Kronos AI 30-day forecast
| Expected close | $25.99 (+79.3%) |
| Likely range | +69.3% … +81.0% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator